Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and-Negative Merkel Cell Carcinoma

被引:7
作者
Durand, Marie-Alice [1 ]
Mouchard, Alice [1 ,2 ]
Durand, Laurine [1 ]
Esnault, Clara [1 ]
Berthon, Patricia [1 ]
Tallet, Anne [3 ]
Le Corre, Yannick [4 ]
Hainaut-Wierzbicka, Ewa [5 ]
Blom, Astrid [6 ,7 ]
Saiag, Philippe [6 ,7 ]
Beneton, Nathalie [8 ]
Bens, Guido [9 ]
Nardin, Charlee [1 ,11 ]
Aubin, Francois [1 ,11 ]
Dinulescu, Monica [1 ,12 ]
Collin, Christine [3 ,10 ]
Fromont-Hankard, Gaelle [13 ]
Cribier, Bernard [1 ,10 ,14 ]
Laurent-Roussel, Sara [1 ,15 ]
Cokelaere, Kristof [16 ]
Houben, Roland [17 ]
Schrama, David [17 ]
Peixoto, Paul [18 ,19 ]
Hervouet, Eric [18 ,19 ]
Bachiri, Kamel [20 ]
Kantar, Diala [20 ]
Coyaud, Etienne [20 ]
Guyetant, Serge
Samimi, Mahtab [1 ,2 ]
Touze, Antoine [1 ]
Kervarrec, Thibault [1 ,13 ,21 ]
机构
[1] Univ Tours, Team Biol Infect Polyomavirus, ISP UMR 1282, INRAE, Tours, France
[2] Univ Tours, Dept Dermatol, CHRU Tours, Chambray Les Tours, France
[3] Univ Tours, CHU Tours, Platform Somat Tumor Mol Genet, Tours, France
[4] LUNAM Univ, CHU Angers, Dept Radiol, Angers, France
[5] Univ Poitiers, Dermatol Dept, CHU Poitiers, Poitiers, France
[6] Ambroise Pare Hosp, Dept Gen & Oncol Dermatol, CARADERM Network, Boulogne Billancourt, France
[7] Paris Saclay Univ, Univ Versailles St Quentin En Yvelines, Res Unit EA 4340, Boulogne Billancourt, France
[8] Univ Le Mans, Dermatol Dept, CHU Mans, Le Mans, France
[9] CHR Orleans, Dermatol Dept, Orleans, France
[10] CHU Besancon, Dermatol, Besancon, France
[11] Univ Bourgogne Franche Comte, INSERM 1098, Besancon, France
[12] CHU Rennes, Inst Dermatol Grand Ouest IDGO, Dermatol Dept, Rennes, France
[13] Univ Tours, CHU Tours, Pathol Dept, Tours, France
[14] Univ Strasbourg, Dermatol Dept, CHU Strasbourg, Strasbourg, France
[15] Natl Dermatopathol Ctr, Paris, France
[16] Reg Hosp Jan Yperman, Pathol Dept, Ieper, Belgium
[17] Univ Hosp Wurzburg, Dept Dermatol Venerol & Allergol, Wurzburg, Germany
[18] Univ Bourgogne Franche Comte, INSERM, EFS BFC, UMR RIGHT 1098, Besancon, France
[19] Univ Bourgogne Franche Comte, EPIgenet & GENe Express Tech Platform EPIGENExp, Besancon, France
[20] Univ Lille, CHU Lille, Prote Reponse Inflammatoire Spectrometrie Masse PR, Inserm,U1192,Dept Biol, Lille, France
[21] CHRU Tours, Hop Trousseau, Dept Pathol, F-37044 Tours, France
关键词
OPEN-LABEL; EXPRESSION; TAZEMETOSTAT; ASSOCIATION; CANCER;
D O I
10.1016/j.jid.2023.02.038
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Merkel cell carcinoma (MCC) is an aggressive skin cancer for which Merkel cell polyomavirus integration and expression of viral oncogenes small T and Large T have been identified as major oncogenic determinants. Recently, a component of the PRC2 complex, the histone methyltransferase enhancer of zeste homolog 2 (EZH2) that induces H3K27 trimethylation as a repressive mark has been proposed as a potential therapeutic target in MCC. Because divergent results have been reported for the levels of EZH2 and trimethylation of lysine 27 on histone 3, we analyzed these factors in a large MCC cohort to identify the molecular determinants of EZH2 activity in MCC and to establish MCC cell lines' sensitivity to EZH2 inhibitors. Immunohistochemical expression of EZH2 was observed in 92% of MCC tumors (156 of 170), with higher expression levels in virus positive than virus-negative tumors (P 1/4 0.026). For the latter, we showed overexpression of EZHIP, a negative regulator of the PRC2 complex. In vitro, ectopic expression of the large T antigen in fibroblasts led to the induction of EZH2 expression, whereas the knockdown of T antigens in MCC cell lines resulted in decreased EZH2 expression. EZH2 inhibition led to selective cytotoxicity on virus-positive MCC cell lines. This study highlights the distinct mechanisms of EZH2 induction between virus-negative and-positive MCC.
引用
收藏
页码:1937 / 1946.e7
页数:17
相关论文
共 60 条
[1]   Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells [J].
Bardot, Evan S. ;
Valdes, Victor J. ;
Zhang, Jisheng ;
Perdigoto, Carolina N. ;
Nicolis, Silvia ;
Hearn, Stephen A. ;
Silva, Jose M. ;
Ezhkova, Elena .
EMBO JOURNAL, 2013, 32 (14) :1990-2000
[2]   Merkel cell carcinoma [J].
Becker, Juergen C. ;
Stang, Andreas ;
DeCaprio, James A. ;
Cerroni, Lorenzo ;
Lebbe, Celeste ;
Veness, Michael ;
Nghiem, Paul .
NATURE REVIEWS DISEASE PRIMERS, 2017, 3
[3]   EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J].
Adrian P. Bracken ;
Diego Pasini ;
Maria Capra ;
Elena Prosperini ;
Elena Colli ;
Kristian Helin .
The EMBO Journal, 2003, 22 (20) :5323-5335
[4]   Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors [J].
Busam, Klaus J. ;
Pulitzer, Melissa P. ;
Coit, Daniel C. ;
Arcila, Maria ;
Leng, Danielle ;
Jungbluth, Achim A. ;
Wiesner, Thomas .
MODERN PATHOLOGY, 2017, 30 (06) :877-883
[5]   The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3 [J].
Cao, R ;
Zhang, Y .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (02) :155-164
[6]   Selective Killing of SMARCA2-and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models [J].
Chan-Penebre, Elayne ;
Armstrong, Kelli ;
Drew, Allison ;
Grassian, Alexandra R. ;
Feldman, Igor ;
Knutson, Sarah K. ;
Kuplast-Barr, Kristy ;
Roche, Maria ;
Campbell, John ;
Ho, Peter ;
Copeland, Robert A. ;
Chesworth, Richard ;
Smith, Jesse J. ;
Keilhack, Heike ;
Ribich, Scott A. .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) :850-860
[7]  
Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
[8]   Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation [J].
Fujii, Satoshi ;
Ito, Kosei ;
Ito, Yoshiaki ;
Ochiai, Atsushi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) :17324-17332
[9]   Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential [J].
Gan, Lu ;
Yang, Yanan ;
Li, Qian ;
Feng, Yi ;
Liu, Tianshu ;
Guo, Weijian .
BIOMARKER RESEARCH, 2018, 6
[10]   SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma [J].
Gandhi, Jatin S. ;
Alnoor, Fnu ;
Sadiq, Qandeel ;
Solares, Jorge ;
Gradowski, Joel F. .
PATHOLOGY RESEARCH AND PRACTICE, 2021, 219